Bellicum Pharmaceuticals, Inc. - stock earnings
BLCM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -763000 USD | 1.0 million USD |
| 2023Q2 | -7.4 million USD | ? USD |
| 2023Q1 | -7.5 million USD | 8000 USD |
| 2022Q4 | -6.2 million USD | 500000 USD |
| 2022Q3 | -7.3 million USD | 1.0 million USD |
| 2022Q2 | -1.5 million USD | ? USD |
| 2022Q1 | -9.2 million USD | ? USD |
| 2021Q4 | 2.5 million USD | 500000 USD |
| 2021Q3 | 1.2 million USD | 5.0 million USD |
| 2021Q2 | -2.2 million USD | 700000 USD |
| 2021Q1 | -11.3 million USD | ? USD |
| 2020Q4 | 18.8 million USD | 500000 USD |
| 2020Q3 | -887000 USD | ? USD |
| 2020Q2 | -43.2 million USD | ? USD |
| 2020Q1 | 17.6 million USD | 5.1 million USD |
| 2019Q4 | -29.0 million USD | 5.1 million USD |
| 2019Q3 | -32.0 million USD | 103000 USD |
| 2019Q2 | -26.9 million USD | 1.4 million USD |
| 2019Q1 | -24.5 million USD | 516000 USD |
| 2018Q4 | -27.2 million USD | 312000 USD |
| 2018Q3 | -23.8 million USD | 292000 USD |
| 2018Q2 | -24.2 million USD | 362000 USD |
| 2018Q1 | -22.8 million USD | 154000 USD |
| 2017Q4 | -21.9 million USD | -69000 USD |
| 2017Q3 | -23.4 million USD | 126000 USD |
| 2017Q2 | -24.5 million USD | 128000 USD |
| 2017Q1 | -22.0 million USD | 128000 USD |
| 2016Q4 | -19.9 million USD | 81000 USD |
| 2016Q3 | -17.7 million USD | 114000 USD |
| 2016Q2 | -16.5 million USD | 101000 USD |
| 2016Q1 | -15.1 million USD | 92000 USD |
| 2015Q4 | -16.8 million USD | 34000 USD |
| 2015Q3 | -13.4 million USD | 57000 USD |
| 2015Q2 | -10.5 million USD | 84000 USD |
| 2015Q1 | -7.8 million USD | 107000 USD |
| 2014Q4 | -74.3 million USD | 15000 USD |
| 2014Q3 | -4.1 million USD | 660000 USD |
| 2014Q2 | -3.3 million USD | 554000 USD |
| 2014Q1 | -2.3 million USD | 552000 USD |
| 2013Q4 | -2.5 million USD | 818958 USD |
| 2012Q4 | ? USD | 1.5 million USD |
BLCM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -22.4 million USD | 1.5 million USD |
| 2022 | -25.0 million USD | 1.5 million USD |
| 2021 | -9.6 million USD | 6.2 million USD |
| 2020 | -8.6 million USD | 500000 USD |
| 2019 | -126.1 million USD | 7.1 million USD |
| 2018 | -98.0 million USD | 1.1 million USD |
| 2017 | -91.8 million USD | 185000 USD |
| 2016 | -69.2 million USD | 388000 USD |
| 2015 | -48.5 million USD | 282000 USD |
| 2014 | -84.0 million USD | 1.8 million USD |
| 2013 | -8.0 million USD | 1.9 million USD |
| 2012 | -6.3 million USD | 1.5 million USD |
BLCM
Price: $0.07
52 week price:
Earnings Per Share: -0.72 USD
P/E Ratio: -0.13
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 39500
Ebitda: -21.5 millionMarket Capitalization: 778326